Literature DB >> 7779122

A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity.

G Stucki1, M H Liang, S Stucki, P Brühlmann, B A Michel.   

Abstract

OBJECTIVE: To examine the psychometric properties and construct validity of a self-administered Rheumatoid Arthritis Disease Activity Index (RADAI).
METHODS: Five items of the Rapid Assessment of Disease Activity in Rheumatology (RADAR) questionnaire were aggregated into the RADAI and assessed for their factor loading, internal consistency, and construct validity.
RESULTS: In 55 patients with RA, the RADAI had a high internal consistency (Cronbach's alpha = 0.91) and correlated with physician's assessment of disease activity (r = 0.54, P < 0.01), the swollen joint count (r = 0.54, P < 0.01), and the C-reactive protein value (r = 0.43, P < 0.01).
CONCLUSION: The RADAI is a highly reliable and valid self-administered measure of disease activity for clinical, health services, and epidemiologic research. Its sensitivity to change in longitudinal studies needs further study.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7779122     DOI: 10.1002/art.1780380612

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  75 in total

1.  The challenge of following process, damage, and function in patients with rheumatoid arthritis in clinical care.

Authors:  Josef S Smolen; Daniel Aletaha
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

2.  Patients with rheumatoid arthritis in clinical care.

Authors:  J S Smolen; D Aletaha
Journal:  Ann Rheum Dis       Date:  2004-03       Impact factor: 19.103

3.  Cognitive impairment in persons with rheumatoid arthritis.

Authors:  So Young Shin; Patricia Katz; Margaret Wallhagen; Laura Julian
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-08       Impact factor: 4.794

4.  Patient's global assessment of disease activity and patient's assessment of general health for rheumatoid arthritis activity assessment: are they equivalent?

Authors:  Nasim Ahmed Khan; Horace Jack Spencer; Essam Ahmed Abda; Rieke Alten; Christof Pohl; Codrina Ancuta; Massimiliano Cazzato; Pál Géher; Laure Gossec; Dan Henrohn; Merete Lund Hetland; Nevsun Inanc; Johannes Wg Jacobs; Eduardo Kerzberg; Maria Majdan; Omondi Oyoo; Ruben A Peredo-Wende; Zahraa Ibrahim Selim; Fotini Nikolaos Skopouli; Alberto Sulli; Kim Hørslev-Petersen; Peter C Taylor; Tuulikki Sokka
Journal:  Ann Rheum Dis       Date:  2012-04-24       Impact factor: 19.103

5.  The subjective components of the Disease Activity Score 28-joints (DAS28) in rheumatoid arthritis patients and coexisting fibromyalgia.

Authors:  Fausto Salaffi; Marco Di Carlo; Marina Carotti; Piercarlo Sarzi-Puttini
Journal:  Rheumatol Int       Date:  2018-06-28       Impact factor: 2.631

Review 6.  [Self-monitoring in inflammatory rheumatic diseases].

Authors:  C Kampling; G Chehab; M Schneider; J G Richter
Journal:  Z Rheumatol       Date:  2014-10       Impact factor: 1.372

7.  The relationship between cognitive function and physical function in rheumatoid arthritis.

Authors:  So Young Shin; Laura Julian; Patricia Katz
Journal:  J Rheumatol       Date:  2013-01-15       Impact factor: 4.666

8.  Work factors and behavioural coping in relation to withdrawal from the labour force in patients with rheumatoid arthritis.

Authors:  A M Chorus; H S Miedema; C W Wevers; S van der Linden
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

9.  Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti-tumour necrosis factor treatment.

Authors:  Peter M ten Klooster; Martine M Veehof; Erik Taal; Piet L C M van Riel; Mart A F J van de Laar
Journal:  Ann Rheum Dis       Date:  2007-05-01       Impact factor: 19.103

10.  Cross-cultural adaptation and validation of the Thai version of the Rheumatoid Arthritis Disease Activity Index (RADAI).

Authors:  Wanruchada Katchamart; Prapassorn Ussavasodhi; Praveena Chiowchanwesawakit; Wanwisa Chanapai
Journal:  Rheumatol Int       Date:  2013-04-16       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.